Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $614,811 - $892,545
3,737 Added 333.66%
4,857 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $217,772 - $243,723
1,120 New
1,120 $219,000
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $4.35 Million - $5.9 Million
-22,687 Reduced 65.36%
12,022 $2.43 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $13.1 Million - $16.6 Million
-66,323 Reduced 65.65%
34,709 $7.56 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $12.1 Million - $16.6 Million
-66,438 Reduced 39.67%
101,032 $19.9 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $12.1 Million - $17.9 Million
59,310 Added 54.84%
167,470 $35.8 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $27.4 Million - $38.8 Million
107,148 Added 10587.75%
108,160 $30.7 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $637,754 - $814,354
-1,815 Reduced 64.2%
1,012 $381,000
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $739,690 - $909,725
1,985 Added 235.75%
2,827 $1.17 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $247,691 - $312,929
842 New
842 $311,000
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $3.82 Million - $4.58 Million
-15,306 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $1.62 Million - $1.85 Million
-7,309 Reduced 32.32%
15,306 $3.82 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $2.27 Million - $2.93 Million
-12,936 Reduced 36.39%
22,615 $5.12 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $2.46 Million - $3.93 Million
-20,693 Reduced 36.79%
35,551 $6.2 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $1.38 Million - $2.48 Million
13,934 Added 32.93%
56,244 $7.1 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $6.28 Million - $7.61 Million
-49,817 Reduced 54.07%
42,310 $6.46 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $3.43 Million - $3.94 Million
27,430 Added 42.4%
92,127 $12.2 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $6.47 Million - $7.78 Million
-52,401 Reduced 44.75%
64,697 $9.18 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $1.68 Million - $2.35 Million
16,011 Added 15.84%
117,098 $17 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $12.5 Million - $16.4 Million
-119,307 Reduced 54.13%
101,087 $11.4 Million
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $7.1 Million - $8.52 Million
63,322 Added 40.31%
220,394 $29.7 Million
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $2.58 Million - $2.95 Million
25,154 Added 19.07%
157,072 $17.6 Million
Q1 2018

May 15, 2018

SELL
$98.19 - $115.2 $28.3 Million - $33.2 Million
-288,049 Reduced 68.59%
131,918 $14.1 Million
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $22.3 Million - $26.2 Million
-221,707 Reduced 34.55%
419,967 $46 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $62.1 Million - $70.1 Million
641,674
641,674 $69.3 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.